Could Urinary Iodine Be an Effective Predictive Factor for Thyroid Cancer After High Dose Radioactive Iodine Therapy?

Objective: The study aimed to investigate whether urinary iodine concentration (UIC) and urinary iodine to creatinine ratio (UICR) measurements can act as markers for the curative effect of radioactive iodine (RAI) therapy. Methods: A total of 337 patients who underwent RAI therapy between May 2018 and March 2020 were recruited. According to the levels of UIC or UICR, patients were divided into 6 groups: group A, UIC levels of < 100 mu g/L; group B, UIC levels ranging from 100 to 200 mu g/L; group C, UIC levels of >= 200 mu g/L; group D, UICR levels of < 100 mu g/g; group E, UICR levels ranging from 100 to 200 mu g/g; and group F, UICR levels of >= 200 mu g/g. Treatment and follow-up were defined according to the criteria used in the 2015 ATA guidelines. Results: When dividing the 337 patients into 3 groups according to UIC levels, 50.7%, 22.6%, and 26.7% of patients were in the A, B, and C groups, respectively. Based on the UICR levels, 58.1%, 29.4%, and 12.5% of patients were in the D, E, and F groups, respectively. There was a significant positive correlation between UIC and UICR levels and iodine-131 uptake rates (P < .001). The excellent response rate was not significantly different between the UIC groups (P = .997) and the UICR groups (P = .634). In logistic regression analysis, UIC and UICR levels were not confirmed to be independent factors predicting the excellent response status, but an age of >= 55 years (OR = 0.373; P = .007) and Tg levels of >= 10 ng/mL (OR = 18.972; P = .001) were confirmed to be independent factors predicting the excellent response status at the end of follow-up. Conclusion: The UIC or UICR levels before RAI therapy did not compromise the therapeutic response to iodine-131. (C) 2022 AACE. Published by Elsevier Inc. All rights reserved.